OHSU research suggests compound administered during some bone marrow transplants elevates risks

Research conducted at Oregon Health and Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe...

Read the whole article on

More from